Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and...
The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV) are known to cause fatal diseases in humans. In 2022, Langya henipavirus (LayV), a novel henipavirus was identified in Eastern...
BX795 is a newly developed broad-spectrum anti-viral drug candidate which can treat infections from Herpes Simplex Virus-1 and possibly from other viruses in both...
Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval. It is a small interfering RNA (siRNA) based therapeutic that interfere with natural anticoagulants such as...
Interspecies Blastocyst Complementation (IBC) (i.e., complementation by microinjecting stem cells of other species into blastocyst-stage embryos) successfully generated rat forebrain tissue in mice which...